Synopsis: UFlex Limited reported its highest quarterly EBITDA in 14 quarters during Q4 FY26, with EBITDA rising 31.8% year-on-year to ₹626.5 crore and margins expanding to 15.3%. As multiple global facilities move into commercial operations, management expects FY27 to deliver stronger revenue growth, higher volumes, and improved profitability.
The EBITDA Inflection Point
For the past several years, UFlex has been investing heavily across packaging films, aseptic packaging, recycling, and international manufacturing facilities. FY26 appears to mark the turning point where those investments are beginning to translate into earnings growth.
UFlex Limited recently released the transcript of its Q4 and FY26 earnings call, where management outlined a clear transition from a capital expenditure cycle to an asset monetization phase. With major projects in India, Egypt, Mexico, and the Americas entering commercialization, management believes FY27 will be meaningfully stronger than FY26.
The significance of the quarter goes beyond earnings growth. Q4 FY26 delivered the company’s highest quarterly EBITDA in 14 quarters, indicating that operating leverage is finally beginning to work in UFlex’s favor.
Shares of UFlex Limited, with a market capitalization of Rs. 3,062.49 crore, are trading at Rs. 424.10, up 0.76% from their previous closing price of Rs. 420.90. The stock touched an intraday high of Rs. 432.00 and a low of Rs. 423.05. It is currently trading at a P/E ratio of 9.27.
Q4 Results Show Profitability Recovery Gaining Momentum
UFlex reported consolidated revenue of ₹4,097.3 crore in Q4 FY26, up 5.7% year-on-year and 12.8% sequentially. The bigger highlight was profitability. EBITDA surged 31.8% year-on-year and 36.3% quarter-on-quarter to ₹626.5 crore, while EBITDA margins expanded by 300 basis points year-on-year to 15.3%. Normalized profit after tax stood at ₹202.6 crore, supported by stronger realizations, improved product mix, and better capacity utilization across key businesses.
For the full year FY26, revenue increased 2.1% to ₹15,513 crore, while EBITDA grew 8.1% to ₹1,983.6 crore. EBITDA margins improved to 12.8%, demonstrating resilience despite challenges such as global tariff uncertainty, supply-chain disruptions, and volatility in packaging film spreads.
The Real Story Is FY27, Not FY26
While FY26 showed improving profitability, management’s primary focus remains on what comes next. Several high-value projects are expected to contribute meaningfully during FY27, creating multiple growth engines simultaneously.
The most important among them is the aseptic packaging business. UFlex has expanded its India aseptic capacity from 7 billion packs to 12 billion packs annually, while a new 12-billion-pack facility in Egypt is expected to commence operations during the first half of FY27.
Management expects total aseptic volumes to increase from approximately 8 billion packs in FY26 to 10 – 10.5 billion packs during FY27. This is particularly important because aseptic packaging is a higher-margin business than traditional packaging films and offers stronger entry barriers due to technology requirements and customer qualification processes.
Egypt Could Become the Next Major Profit Driver
The Egypt aseptic facility represents more than just additional production capacity it could become a significant profitability catalyst. Strategically located between Europe, the Middle East, and Africa, the facility provides access to multiple high-growth export markets while benefiting from competitive operating costs.
As utilization ramps up, investors will closely monitor whether the Egypt operation can generate superior margins compared to the existing India business. If successful, it could emerge as one of the company’s most important EBITDA contributors over the next few years.
The facility also strengthens UFlex’s position in a market currently dominated by a limited number of global aseptic packaging players, creating an opportunity to capture market share in fast-growing emerging economies.
Recycling and Sustainability Open a New Growth Avenue
The company recently commissioned a 36,000 TPA rPET recycling facility and a 3,600 TPA recycled multi-layer plastic (rMLP) facility in India. These investments position UFlex to benefit from the growing global focus on circular economy solutions and recycled packaging materials.
Beyond regulatory compliance, recycling provides an opportunity to move further into value-added specialty packaging products, reducing dependence on commodity film cycles.
For institutional investors, particularly ESG-focused funds, these investments improve the company’s sustainability profile and strengthen its long-term competitive positioning.
Mexico and the Americas Are Changing the RevenueMix
A key contributor to the Q4 recovery was the Americas region, where volumes grew 23% sequentially and 18% year-on-year. This trend is expected to continue as the company’s newly commissioned woven polypropylene (WPP) bag facility in Mexico ramps up operations.
The facility, which has an annual capacity of 80 million bags, targets the premium North American pet food market a segment that typically offers better margins and stronger pricing power than traditional packaging applications.
As these businesses scale, UFlex’s revenue mix is gradually shifting toward higher-realization international markets, reducing dependence on the highly competitive domestic packaging industry and providing greater diversification across geographies.
The Balance Sheet Remains the Key Re-Rating Trigger
Despite the strong operational performance, investors continue to focus on one major issue: leverage. UFlex ended FY26 with consolidated debt of approximately ₹8,500 crore and a net debt-to-EBITDA ratio of 4.35x, improving from 4.51x in the previous quarter.
The good news is that the company appears to be nearing the end of its heavy investment cycle. Capital work-in-progress stood at ₹2,169 crore as of March 2026, with management expecting approximately ₹1,900 – 2,000 crore of assets to be capitalized during FY27. As these assets begin contributing to earnings, management expects leverage ratios to steadily decline.
This is particularly important because many investors believe the stock’s valuation discount is largely driven by concerns around debt levels. A sustained reduction in net debt-to-EBITDA toward 3x could become a major catalyst for a market re-rating.
Company Overview
UFlex Limited is India’s largest multinational flexible packaging and packaging solutions company with operations spanning packaging films, aseptic liquid packaging, recycling, printing inks, adhesives, holography solutions, laminates, pouches, and woven polypropylene bags.
Headquartered in Noida, the company operates manufacturing facilities across India, the Americas, Europe, Africa, and Asia, serving leading global FMCG, food, beverage, pharmaceutical, and personal care companies. As multiple international facilities enter commercialization, UFlex is transitioning from an investment-heavy phase to a period focused on asset utilization, EBITDA growth, and balance-sheet strengthening.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
